<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Denvir MA</submitter><funding>Marie Curie</funding><pagination>24619</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4836296</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>6</volume><pubmed_abstract>Future Care Planning (FCP) rarely occurs in patients with heart disease until close to death by which time the potential benefits are lost. We assessed the feasibility, acceptability and tested a design of a randomised trial evaluating the impact of FCP in patients and carers. 50 patients hospitalised with acute heart failure or acute coronary syndrome and with predicted 12 month mortality risk of >20% were randomly allocated to FCP or usual care for 12 weeks upon discharge and then crossed-over for the next 12 weeks. Quality of life, symptoms and anxiety/distress were assessed by questionnaire. Hospitalisation and mortality events were documented for 6 months post-discharge. FCP increased implementation and documentation of key decisions linked to end-of-life care. FCP did not increase an</pubmed_abstract><journal>Scientific reports</journal><pubmed_title>Phase 2 Randomised Controlled Trial and Feasibility Study of Future Care Planning in Patients with Advanced Heart Disease.</pubmed_title><pmcid>PMC4836296</pmcid><funding_grant_id>A15867</funding_grant_id><pubmed_authors>Robertson S</pubmed_authors><pubmed_authors>Donald L</pubmed_authors><pubmed_authors>Murray SA</pubmed_authors><pubmed_authors>Weir CJ</pubmed_authors><pubmed_authors>Highet G</pubmed_authors><pubmed_authors>Boyd K</pubmed_authors><pubmed_authors>Cudmore S</pubmed_authors><pubmed_authors>Stephen J</pubmed_authors><pubmed_authors>Haga K</pubmed_authors><pubmed_authors>Denvir MA</pubmed_authors><pubmed_authors>Hogg K</pubmed_authors></additional><is_claimable>false</is_claimable><name>Phase 2 Randomised Controlled Trial and Feasibility Study of Future Care Planning in Patients with Advanced Heart Disease.</name><description>Future Care Planning (FCP) rarely occurs in patients with heart disease until close to death by which time the potential benefits are lost. We assessed the feasibility, acceptability and tested a design of a randomised trial evaluating the impact of FCP in patients and carers. 50 patients hospitalised with acute heart failure or acute coronary syndrome and with predicted 12 month mortality risk of >20% were randomly allocated to FCP or usual care for 12 weeks upon discharge and then crossed-over for the next 12 weeks. Quality of life, symptoms and anxiety/distress were assessed by questionnaire. Hospitalisation and mortality events were documented for 6 months post-discharge. FCP increased implementation and documentation of key decisions linked to end-of-life care. FCP did not increase an</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Apr</publication><modification>2025-04-04T11:41:18.553Z</modification><creation>2019-03-27T02:11:54Z</creation></dates><accession>S-EPMC4836296</accession><cross_references><pubmed>27090299</pubmed><doi>10.1038/srep24619</doi></cross_references></HashMap>